EDGAR Filing Documents for 0001140361-17-015797

Form 8-K - Current report:

SEC Accession No. 0001140361-17-015797

Filing Date

2017-04-13

Accepted

2017-04-13 16:33:44

Documents

Period of Report

2017-04-11

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	form8k.htm	8-K	49027
2	EXHIBIT 10.1	ex10_1.htm	EX-10.1	7437
3	EXHIBIT 99.1	ex99_1.htm	EX-99.1	9771
4		image0.jpg	GRAPHIC	79335
	Complete submission text file	0001140361-17-015797.txt		176965

Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850

Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300

REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)